【API registration information】
| Drug Name | Dosage Form | Drug Standard No | Import Registration Certificate No | Certificate Expiry Date | Expiration Date | Package |
| 培哚普利叔丁胺盐 | API | JX20140023 | H20140794/
H20140795 | 2019-10-16
| 36 months
| 1kg/barrel;，2kg/barrel，5kg/barrel，10kg/barrel |
Manufacturing Enterprise：Glenmark Generics Limited
[Name of Drug]
General Name/English Name：Perindopril Tert-Butylamine
Chemical Name: 2-methylpropane-2-amine (2S, 3As, 7As) - 1 - [(2S) - 2 - [[(1s) - 1 - (ethoxycarbonyl) butyl] amino] propionyl] octahydro-1h-indole-2-carboxylic acid TERT butylamine salt
Structural Formula：
![Perindopril Tert-Butylamine 培哚普利叔丁胺盐]( "Perindopril Tert-Butylamine 培哚普利叔丁胺盐")
Molecular formula: c23h43n3o5
Molecular weight: 441.6
CAS No.: 107133-36-8
[Properties] This product is white or almost white crystalline powder, slightly hygroscopic.
[Manufacturer Profile]
![Perindopril Tert-Butylamine 培哚普利叔丁胺盐]( "Perindopril Tert-Butylamine 培哚普利叔丁胺盐")
Glenmark pharmaceuticals is a pharmaceutical company headquartered in Mumbai, India, founded in 1977 by Gracias Saldanha as a manufacturer of generic and active pharmaceutical ingredients; he named the company after his two sons. The company initially sold its products in India, Russia and Africa. The company went public in India in 1999 and used some of the proceeds to build its first research institution. Saldanha's son Glenn took over as CEO in 2001 and returned to India after working for PricewaterhouseCoopers. By 2008, granken was the fifth largest pharmaceutical company in India.